Photodynamic Therapy for Superficial Cancer in the Oesophagus and Bronchi
Author Information
Author(s): P Grosjean, G Wagnieres, C Fontolliet, H van den Bergh, P Monnier
Primary Institution: CHUV Hospital, Switzerland
Hypothesis
Does photodynamic therapy with 514 nm light provide a safer and equally effective treatment for superficial cancers compared to 630 nm light?
Conclusion
Photodynamic therapy with 514 nm light is effective for treating superficial cancers in the oesophagus and bronchi, with a lower risk of complications compared to 630 nm light.
Supporting Evidence
- Six of nine tumours treated with 514 nm light had a complete response.
- Nine of thirteen tumours treated with 630 nm light had a complete response.
- No perforation or fistula occurred in either treatment group.
- Severe chest pain and fever were observed in three patients after 630 nm treatment.
Takeaway
Doctors used a special light to treat early cancers in the throat and lungs, and found that a different color light was just as good but safer.
Methodology
Fifteen patients with superficial squamous cell carcinomas were treated with photodynamic therapy using either 514 nm or 630 nm light after sensitization with Photofrin II.
Potential Biases
Potential bias due to the voluntary nature of patient enrollment and previous treatments received by patients.
Limitations
The small sample size and the lack of long-term follow-up data limit the generalizability of the findings.
Participant Demographics
12 men and 3 women, mean age 59.8 years, range 46-79 years.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website